SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-016743
Filing Date
2021-02-09
Accepted
2021-02-09 17:00:42
Documents
2
Group Members
AESCAP VENTURE MANAGEMENT B.V.JOHAN GERHARD BOSMANMICHIEL ALEXANDER DE HAANPATRICK JOHAN HENDRIK KROL

Document Format Files

Seq Description Document Type Size
1 SC 13G tm215754d1_sc13g.htm SC 13G 86449
2 EXHIBIT 99.1 tm215754d1_ex99-1.htm EX-99.1 7896
  Complete submission text file 0001104659-21-016743.txt   95962
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Subject) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92107 | Film No.: 21607399
SIC: 2834 Pharmaceutical Preparations

Mailing Address BARBARA STROZZILAAN 101 AMSTERDAM P7 1083 HN
Business Address BARBARA STROZZILAAN 101 AMSTERDAM P7 1083 HN 31 20 570 29 45
Cooperatieve AESCAP Venture I U.A. (Filed by) CIK: 0001834629 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G